Navigation Links
Beyond lithium for bipolar disorder

While lithium treatment has proven to be a godsend for many of the two million Americans with bipolar disorder, it is not without its downside. People on the drug may develop hypothyroidism, tremors, cognitive impairment, and excessive thirst and urination and gain weight.

However, better treatments for bipolar disorder depend on a better understanding of the still-mysterious mechanism by which lithium damps the highs and lows of the disorder. Now, researchers led by Philip Brandish of Merck & Co., Inc., and Edward Scolnick of the Broad Institute (formerly of Merck and Co., Inc.) have identified genes whose activity appears to be switched on by lithium, suggesting more direct targets for drugs to treat the disorder.

Lithium is known to inhibit the production of an important cellular switch, called inositol monophosphate, so the researchers set out to find genes that were activated by this inhibition. They treated slices of rat brain with lithium chloride as well as a chemical that depletes inositol. The also treated other slices with the two chemicals, but added inositol.

The researchers used DNA microarrays--so-called "gene chips"--to detect genes that were unequivocally activated when inositol was depleted in the brain slices.

They discovered several genes that they concluded "suggest new directions toward the treatment of bipolar disorder."

The behavior of one such activated gene, called GPR88, has been found to be associated with a rat model of mania, they said. This gene codes for a protein that is an "orphan receptor"--that is, its cellular function in sensing external chemical signals is unknown.

The researchers also found that the gene called AD-CYAP1 was upregulated in the treated brain slices. This gene codes for a signaling molecule called PACAP in the brain and is known to be close to a chromosomal region that genetic studies have shown to be associated with a higher risk of bipolar disorder.

PAC
'"/>

Source:Cell Press


Page: 1 2

Related biology news :

1. Beyond genes: Lipid helps cell wall protein fold into proper shape
2. Beyond the book: Software automates access to brain atlases
3. Beyond the DNA: Chemical signatures reveal genetic switches in the genome
4. Clock molecules sensitivity to lithium sheds light on bipolar disorder
5. New gene linked to bipolar disorder
6. Lithium builds gray matter in bipolar brains, UCLA study shows
7. Genetic roots of bipolar disorder revealed by first genome-wide study of illness
8. Mouse brain tumors mimic those in human genetic disorder
9. Iron exporter revealed that may explain common human disorder
10. Pinpointing the cause of a neurodegenerative disorder
11. Researchers track down cause of a disfiguring bone disorder
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Beyond lithium for bipolar disorder

(Date:12/17/2014)... 15, 2014 Research and Markets ( http://www.researchandmarkets.com/research/s6qzt5/samsung_galaxy_s5 ... Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology ... http://photos.prnewswire.com/prnh/20130307/600769 Based on a ... introduces for the first time a fingerprint sensor in ...
(Date:12/17/2014)... , Dec. 16, 2014 Research and Markets ... "Global Chemical Sensor Market 2015-2019" report to ... One major trend upcoming in this market ... applications. Chemical sensors help in recording of patient data ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition of ... to their offering. One major trend ... biometric systems. Multimodal biometric systems utilize more than one ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... the 21st century, the temperature in the Baltic Sea will ... time since 1850. If no action is taken to alleviate ... for the marine environment. "This is the first time ... models and individual factors combine to affect a specific region. ...
... Oct. 11, 2012 /PRNewswire-iReach/ -- Buffalo Grove, Illinois-based specialty-oncology drug ... that the US Food and Drug Administration (FDA) ... Pre-Investigational New Drug (pre-IND) meeting to discuss its ... a treatment for various cancer indications. The meeting ...
... Calif., Oct. 16, 2012  AVT, Inc. (Ticker: AVTC) ( ... line of self-service medicine storage and retrieval systems for ... for Medbox RX, a leader in storage and dispensing ... The Medbox RX Medication Storage and Retrieval System, called ...
Cached Biology News:Climate change threatens marine environment in the Baltic Sea 2FDA Grants Meridian Laboratories Pre-Ind Meeting for Captisol-Enabled Docetaxel in the Treatment of Cancer 2AVT Develops Biometrically Secure Medicine Storage and Retrieval System for Medbox RX 2
(Date:1/22/2015)... , Jan. 22, 2015   GenoSpace , a precision ... tools to enable the broad use of genomic, imaging and ... the appointment of Michelle Munson , CEO of Aspera, ... Logo - http://photos.prnewswire.com/prnh/20150122/170713 ...
(Date:12/25/2014)... report “Service Quality Management and Telco Customer Experience Management ... Advancements, Worldwide Forecasts & Analysis (2014-2019)” defines and segments ... revenues. , Browse 152 market data tables, 19 ... “Service Quality Management (SQM) and Telco Customer Experience Management ...
(Date:12/24/2014)... and NEW YORK , Dec. ... biopharmaceutical company advancing patient care in critical areas, announced the ... common stock, and warrants to purchase up to an aggregate ... $4.00 per share and $.01 per warrant.  The warrants have ...
(Date:12/24/2014)... 24, 2014   BioLife Solutions , Inc. (NASDAQ: ... clinical grade hypothermic storage and cryopreservation freeze ... cells and tissues  ("BioLife" or the "Company"), today announced that ... May 4, 2015 (the "Annual Meeting"). Because the ...
Breaking Biology Technology:GenoSpace Expands Board with Appointment of Michelle Munson 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 3Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 4PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3BioLife Solutions Sets Date for Annual Meeting of Stockholders 2
... ... that QTc Prolonging Drug is Not Pro-Arrhythmic , ... Rochester, NY (PRWEB) September 9, 2009 -- iCardiac Technologies, ... that its full suite of advanced cardiac safety methods including Highly Automated QT(sm), Dynamic ...
... , MADISON, Wis., Sept. 8 From the transfection ... IT(R)-2020 Transfection Reagent. , , Mirus has expanded ... broad spectrum DNA transfection reagent which offers users: , , ... HD, Lipofectamine(TM) 2000 and Lipofectamine(TM) 2000 CD in many cell types. ...
... , , SEATTLE, Sept. ... announced today that executives will present a corporate update at ... City. Peter Thompson, M.D., FACP, president, chief executive officer and ... vice president and chief financial officer, are scheduled to present ...
Cached Biology Technology:iCardiac's COMPAS Analytics Used in Recent New Drug Approval 2Trubion Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Conference 2